(Q46611174)

23 December 2017

title

A phase I clinical and pharmacokinetic study of fenretinide combined with paclitaxel and cisplatin for refractory solid tumors (English)

1 reference

23 December 2017

1 reference

1 reference

Otterson GA

1

1 reference

23 December 2017

Lavelle J

2

1 reference

23 December 2017

Villalona-Calero MA

3

1 reference

23 December 2017

Shah M

4

1 reference

23 December 2017

Wei X

5

1 reference

23 December 2017

Chan KK

6

1 reference

23 December 2017

Fischer B

7

1 reference

23 December 2017

Grever M

8

1 reference

23 December 2017

publication date

1 December 2005

1 reference

23 December 2017

Investigational New Drugs

published in

1 reference

23 December 2017

volume

23

1 reference

23 December 2017

issue

6

1 reference

23 December 2017

page(s)

555-562

1 reference

23 December 2017

https://scigraph.springernature.com/pub.10.1007/s10637-005-1665-2

exact match

0 references

cites work

Sequence dependence of paclitaxel (Taxol) combined with cisplatin or alkylators in human cancer cells

1 reference

12 December 2020

Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms.

1 reference

12 December 2020

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

12 December 2020

Phase II clinical trial of N-(4-Hydroxyphenyl)retinamide and tamoxifen administration before definitive surgery for breast neoplasia

1 reference

12 December 2020

Tolerability of the synthetic retinoid Fenretinide (HPR)

1 reference

12 December 2020

Inhibition of proliferation and induction of apoptosis in cervical carcinoma cells by retinoids: implications for chemoprevention

1 reference

12 December 2020

Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells

1 reference

12 December 2020

Increase of ceramide and induction of mixed apoptosis/necrosis by N-(4-hydroxyphenyl)- retinamide in neuroblastoma cell lines

1 reference

12 December 2020

Phase II trial of fenretinide in advanced renal carcinoma

1 reference

12 December 2020

Effects of pretreatment with the retinoid N-(4-hydroxyphenyl)-all-trans-retinamide and phenobarbital on the disposition and metabolism of N-(4-hydroxyphenyl)-all-trans-retinamide in mice

1 reference

12 December 2020

Retinoids as preventive and therapeutic anticancer agents (Part I).

1 reference

12 December 2020

N-(4-hydroxyphenyl)retinamide induces apoptosis of malignant hemopoietic cell lines including those unresponsive to retinoic acid

1 reference

12 December 2020

Five-year administration of fenretinide: pharmacokinetics and effects on plasma retinol concentrations

1 reference

12 December 2020

Effects of meals and meal composition on the bioavailability of fenretinide

1 reference

12 December 2020

Phase I trial and pharmacokinetics of fenretinide in children with neuroblastoma.

1 reference

12 December 2020

Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines

1 reference

12 December 2020

Phase II study of fenretinide (NSC 374551) in adults with recurrent malignant gliomas: A North American Brain Tumor Consortium study

1 reference

12 December 2020

Growth inhibition and induction of apoptosis by fenretinide in small-cell lung cancer cell lines.

1 reference

12 December 2020

Retinoids and apoptosis: implications for cancer chemoprevention and therapy

1 reference

12 December 2020

N-(4-hydroxyphenyl)retinamide: a Potent Inducer of Apoptosis in Human Neuroblastoma Cells

1 reference

12 December 2020

Pharmacokinetic Model to Describe Self‐Induced Decreases in Steady‐State Concentrations of Carbamazepine

1 reference

12 December 2020

4-Hydroxyphenylretinamide in the chemoprevention of cancer

1 reference

12 December 2020

Pilot trial of the safety, tolerability, and retinoid levels of N-(4-hydroxyphenyl) retinamide in combination with tamoxifen in patients at high risk for developing invasive breast cancer

1 reference

12 December 2020

Activity of fenretinide plus chemotherapeutic agents in small-cell lung cancer cell lines

1 reference

12 December 2020

Effects of dietary N-(4-hydroxyphenyl)retinamide on N-nitrosomethylbenzylamine metabolism and esophageal tumorigenesis in the Fischer 344 rat.

1 reference

12 December 2020

Phase I/II trial of tamoxifen with or without fenretinide, an analog of vitamin A, in women with metastatic breast cancer

1 reference

12 December 2020

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

1 reference

12 December 2020

Paclitaxel couplets with cyclophosphamide or cisplatin in metastatic breast cancer.

1 reference

12 December 2020

10.1007/S10637-005-1665-2

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017